XML 37 R28.htm IDEA: XBRL DOCUMENT
v3.23.2

Notes to the Consolidated Statements of Operations - Revenue from contract with customers (Details) - EUR (€) € in Thousands | 3 Months Ended | 6 Months Ended
--- | --- | ---
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022
Notes to the Consolidated Statements of Operations |  |  |  |
Total revenues | € 7,579 | € 20,146 | € 14,708 | € 44,519
Research services combined with an IP license |  |  |  |
Notes to the Consolidated Statements of Operations |  |  |  |
Total revenues |  |  | 8,545 | 31,818
Product |  |  |  |
Notes to the Consolidated Statements of Operations |  |  |  |
Total revenues |  |  | 903 | 431
Research and development services |  |  |  |
Notes to the Consolidated Statements of Operations |  |  |  |
Total revenues |  |  | 5,260 | 12,270
Belgium | GSK |  |  |  |
Notes to the Consolidated Statements of Operations |  |  |  |
Total revenues | 6,283 | 19,295 | 12,756 | 43,041
Switzerland | CRISPR |  |  |  |
Notes to the Consolidated Statements of Operations |  |  |  |
Total revenues | 844 | 406 | 1,053 | 586
Netherlands | Genmab |  |  |  |
Notes to the Consolidated Statements of Operations |  |  |  |
Total revenues | € 452 | € 445 | € 899 | € 892

X
- Definition Represents of disclosure of notes to the consolidated financial statements. + References No definition available. + Details
Name: | cvac_DisclosureOfNotesToConsolidatedFinancialStatementsLineItems
Namespace Prefix: | cvac_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity’s ordinary activities in exchange for consideration. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 15 -IssueDate 2022-03-24 -Paragraph 114 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2022-en-r&anchor=para_114&doctype=Standard -URIDate 2022-03-24 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 15 -IssueDate 2022-03-24 -Paragraph 113 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2022-en-r&anchor=para_113_a&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_RevenueFromContractsWithCustomers
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | ifrs-full_ProductsAndServicesAxis=cvac_ResearchServicesCombinedWithIpLicenseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ProductsAndServicesAxis=cvac_IfrsProductMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ProductsAndServicesAxis=cvac_ResearchAndDevelopmentServicesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_GeographicalAreasAxis=country_BE
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_MajorCustomersAxis=cvac_GlaxosmithklineMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_GeographicalAreasAxis=country_CH
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_MajorCustomersAxis=cvac_CrisprMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_GeographicalAreasAxis=country_NL
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_MajorCustomersAxis=cvac_GenmabMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |